Clinical Trial Update: Chidamide With PET Regimen for Angioimmunoblastic T Cell Lymphoma (PET: Prednisone, Etoposide and Thalidomide) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating chidamide in combination with a PET regimen (Prednisone, Etoposide, Thalidomide) for angioimmunoblastic T-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angioimmunoblastic T-cell Lymphoma

Drugs mentioned

• Chidamide (chidamide)

Snippet

Sponsor: Qingdao University | Conditions: Angioimmunoblastic T-cell Lymphoma | Phase 2 | Status: UNKNOWN